Justin Brink

Justin Brink began their career in 2005 as a Production Scientist at EMD Biosciences. In 2007, they moved to Gentel Biosciences as a Product Development Scientist. In 2011, they joined nPoint, Inc. as a Marketing Manager and Account Executive. In 2016, they were appointed Chief Operating Officer and Director of Marketing at BellBrook Labs. In this role, they were responsible for providing innovative lead discovery and optimization tools for researchers around the world and developing first-in-class small molecule drugs targeting cancer and autoimmunity pathways. Justin also oversaw the development of BellBrook HTS Assays - Transcreener and AptaFluor, which are universal high throughput screening assays for enzymes using direct detection of nucleotides and homogenous fluorescent readouts.

Justin Brink attended the Wisconsin School of Business from 2009 to 2012, where they earned a Master of Business Administration (M.B.A.). Justin then attended Bemidji State University from 2001 to 2005, where they earned a B.S. in Biology/Chemistry.